Abstract-Samples of influent (untreated) and effluent (treated) from 18 sewage treatment plants (STPs) in 14 municipalities in Canada were analyzed for residues of selected prescription and nonprescription drugs. Several neutral and acidic drugs were detected in effluents, including analgesic/anti-inflammatory agents, lipid regulators, and an antiepileptic drug, carbamazepine. Residues were extracted from effluents by solid-phase extraction, followed by either methylation and analysis of acidic drugs by gas chromatography/ mass spectrometry or direct analysis of neutral drugs by liquid chromatography/tandem mass spectrometry. Analgesic/anti-inflammatory drugs such as ibuprofen and naproxen, as well as the metabolite of acetylsalicyclic acid, salicylic acid, were often detected in final effluents at g/L concentrations. The acidic lipid regulator, clofibric acid, and the analgesic/anti-inflammatory drug diclofenac were not detected in any final effluent samples, which is not consistent with data from Europe. The precursor to clofibric acid, clofibrate, is not widely prescribed as a lipid regulator in Canada. However, the lipid regulators bezafibrate and gemfibrozil were detected in some samples of influent and effluent. The chemotherapy drugs ifosfamide and cyclophosphamide and the anti-inflammatory phenazone were not detected in influent or effluent samples, but the vasodilator drug pentoxyfylline was detected at ng/L concentrations in some final effluents. The widespread occurrence of carbamazepine at concentrations as high as 2.3 g/L may be explained by use of this drug for other therapeutic purposes besides treatment of epilepsy and its resistance to elimination in STPs. The rates of elimination of ibuprofen and naproxen appeared to be elevated in STPs with hydraulic retention times for sewage greater than 12 h.
INTRODUCTION
Prescription and nonprescription pharmaceutical drugs are produced and used in quantities that exceed hundreds of metric tons annually [1, 2] . Most of these drugs or their metabolites are excreted or are discarded into domestic wastewaters and eventually make their way to sewage treatment plants (STPs), where the potential exists for these chemicals to be discharged in effluents or to be landfilled with biosolids [1, 2] . The potential for a drug to enter the environment depends on the amount sold, the pharmacokinetic behavior of the drug in humans, and the rates of chemical, microbial, or photolytic degradation of the compounds in the environment, including removal from the sewage in STPs. Halling-Sorenson et al. [1] , Daughton and Ternes [3] , and Heberer [4] recently reviewed information on the environmental occurrence of many prescription and nonprescription drugs, and these reviews present evidence that significant quantities of several classes of drugs have the potential to be discharged into the environment.
In the United Kingdom [5, 6] , several drugs were detected in surface waters at concentrations up to approximately 1 g/ L. In Vancouver, Canada, two analgesic/anti-inflammatory drugs, ibuprofen and naproxen, were identified in municipal wastewater [7] . In the mid-1970s, daily discharges of drugs from the STP in Kansas City (KS, USA) were estimated as 28.7 kg/d for salicyclic acid and 2.9 kg/d for clofibric acid [8] . The composition of drugs in STP effluents is likely to have changed considerably since then. A variety of lipid-reg-ulating agents, antiphlogistics, beta-blockers, beta 2 -sympathomimetics, antibiotics, and synthetic estrogens have been identified in STP effluents by investigators in Germany [2, 4, [9] [10] [11] . Analyses of samples of potable water in northern Europe have generally shown that concentrations of drugs in drinking water are extremely low or below detection limits. However, concentrations of drugs are often relatively high in rivers and streams near discharges from STPs [2, 4, 12] .
Our study objective was to evaluate the occurrence and concentrations of prescription and nonprescription drugs in the effluents of sewage treatment facilities in Canada. Neutral and acidic drugs were selected for analysis, based on the availability of analytical methods [9, 11] and evidence that these drugs occur at ng/L to g/L concentrations in STPs in Europe [2] [3] [4] . Wastewaters were collected prior to treatment (influent) and after treatment (effluent) from 18 sewage treatment facilities located in 14 municipalities across Canada. Among the STPs sampled, treatment technologies varied from primary treatment to tertiary treatment. Extracts prepared from wastewater samples were analyzed directly by liquid chromatography/tandem mass spectrometry (LC-MS/MS) for selected neutral drugs or were derivatized and analyzed by gas chromatography/mass spectrometry (GC-MS) for selected acidic drugs.
EXPERIMENTAL

Study sites
Samples of influent (raw sewage) and effluent (final treated sewage) were collected by the sewage treatment utilities in Table 1 , where the facilities are coded with an identification number.
The sewage treatment facilities were located in 14 municipalities in five different provinces across Canada (Fig. 1) . The STPs sampled in major cities with populations Ͼ500,000 included Montreal in the province of Quebec (n ϭ 1), Toronto in the province of Ontario (n ϭ 1), Winnipeg in the province of Manitoba (n ϭ 2), Calgary in the province of Alberta (n ϭ 1), and Vancouver in the province of British Columbia (n ϭ 1). The STPs sampled from smaller cities with populations Ͻ500,000 were all located in the province of Ontario, including STPs in Cambridge (n ϭ 1), Burlington (n ϭ 1), and London (n ϭ 3). The STPs sampled from small municipalities with populations Ͻ50,000 were also all located in the province of Ontario, including Mitchell, Stratford, and Ingersol. Finally, sewage treatment lagoons were sampled from the small communities (population Ͻ10,000) of Tavistock, Port Stanley, Aylmer, and Belmont in the province of Ontario.
Process types in the STPs sampled included primary (n ϭ 1), secondary (n ϭ 10), and tertiary (n ϭ 3) treatment technologies (Table 1 ). In the four smallest communities, domestic waste was held in a sewage lagoon and periodically discharged. In most cases, either chlorine or ultraviolet disinfection of final STP effluents was applied, either seasonally during the warmer months or year-round (Table 1 ). In three STPs and in all discharges from sewage lagoons, no disinfection of the final effluent was applied. In general, wastewaters entering the STPs originated from domestic and light industry sources, but in a few cases the influents were primarily from domestic sources only (Table 1) .
Sample collection
Samples of influent and effluent were collected on the same day from STPs with primary, secondary, or tertiary treatment, using refrigerated autosamplers. Collection involved sampling of defined volumes every 20 min to obtain a composite sample over a 24-h period. In municipalities with lagoon treatment only, grab samples were collected from the influent and from the lagoon cell that was scheduled to be discharged (effluent). All four lagoons were sampled within one month of the scheduled autumn discharge. On the day of sampling, all influent and effluent samples were transported on ice in glass sample containers to Burlington (ON, Canada), where the samples were stored overnight in a refrigerated storage room prior to extraction by a commercial laboratory that was contracted to conduct sample extraction.
Solid-phase extraction of acidic drugs
Because of the large geographical distribution of sampling sites in this study, the samples of STP influents and effluents were collected and extracted onto solid-phase extraction (SPE) cartridges by personnel other than those that prepared the cartridges and conducted the analyses. For this reason, it was not possible to spike effluent samples with surrogate standards prior to SPE extraction. An internal standard for acidic drugs, meclofenamic acid, was added to the extract just before the derivatization step, so analysis of this compound provided information only on the efficiency of methylation of acidic drugs.
Extraction methods for influent and effluent samples to be analyzed for acidic drugs were based on the methods described by Ternes et al. [9] . However, SPE cartridges were different than those previously reported, reflecting the availability of SPE materials in North America. Samples were extracted with SPE cartridge materials purchased from Supelco (Toronto, ON, Canada) and consisted of 0.5 g of LiChrolut 100 RP-18 (40-63 m; Merck, Darmstadt, Germany) solid-phase material manually packed into 6-ml polypropylene cartridges. The cartridges were packed and conditioned at Trent University (Peterborough, ON, Canada) prior to shipping to the contract laboratory that conducted the extractions of influent and effluent samples. The cartridges were conditioned by sequentially eluting with 6 ml n-hexane, 3 ml acetone, 6 ml methanol, and 2 ml water adjusted to pH 2 with 3.5 M H 2 SO 4 .
Samples of influent and effluent (250 ml) were filtered through 1.0-m nominal mesh glass-fiber filters that had been prewashed with hexane and dichloromethane in a Soxhlet apparatus. The pH of the samples was then adjusted to 2 with 3.5 M H 2 SO 4. Samples were aspirated through SPE cartridges at a rate of approximately 20 ml/min. After passage of the sample through the cartridge and aspiration to dryness, the cartridges were wrapped in aluminum foil and shipped refrigerated to Trent University. At Trent, cartridges were dried again for 1 h under a stream of nitrogen and were then extracted by eluting with three successive 1-ml aliquots of methanol (highperformance liquid chromatography [HPLC] grade). Each aliquot of methanol was eluted through the column for a minimum of 10 min.
In order to determine recoveries of the analytes from extraction cartridges, distilled water was spiked with acidic drugs at concentrations of 500 ng/L. Flow rates through the cartridges were optimized for best recoveries and times to extraction. Average recoveries (n ϭ 3) were comparable to previously reported values [9] at 51% for salicylic acid, 65% for clofibric acid, 84% for gemfibrozil, 82% for bezafibrate, 78% for ibuprofen, 79% for fenoprofen, 75% for ketoprofen, 85% for diclofenac, 93% for naproxen, and 87% for meclofenamic acid (internal standard). These recovery efficiencies for compounds dissolved in distilled water will not necessarily reflect the recoveries of analytes within effluent matrices.
Solid-phase extraction of neutral drugs
Since the samples of STP influents and effluents were collected and extracted onto SPE cartridges by personnel other than those that prepared the cartridges and conducted the analyses, it was not possible to spike effluent samples with surrogate standards prior to SPE extraction. An internal standard for neutral drugs (dihydrocarbamazepine) was added just before evaporation of samples to the final sample volume, so analysis of this internal standard provided only a check on the precision of this procedure.
Extraction of influent and effluent samples for neutral drugs was essentially as described by Ternes et al. [11] , except that SPE cartridges and solid phases were purchased from Supelco (Toronto, ON, Canada). Samples were extracted with Supelclean LC-18 SPE cartridges (Supelco) containing 0.5 g of C18 end-capped solid-phase material in a 6-ml polypropylene cartridge. The SPE cartridges were conditioned at Trent University by sequentially eluting with 6 ml n-hexane, 3 ml acetone, 6 ml methanol, 2 ml dechlorinated water adjusted to pH 7.5 with 1 M NaOH, 2 ml (CH 3 ) 4 NOH (1 g/L in water, pH 7.5), and 10 ml dechlorinated water (pH 7.5).
Samples (250 ml) of influent and effluent were filtered through 1.0-m nominal mesh glass-fiber filters as described previously, and the pH of the sample was adjusted to 7.5 with 1 M NaOH. Samples were aspirated through the SPE cartridges at a rate of approximately 20 ml/min. After passage of the sample through the cartridge and aspiration to dryness, the SPE cartridges were wrapped in aluminum foil and shipped refrigerated to Trent University. At Trent, cartridges were dried again for 1 h under a stream of nitrogen and were then extracted by eluting with four successive 1-ml aliquots of methanol (HPLC grade). Each aliquot of methanol was eluted through the column for a minimum of 10 min. After elution, the sample was evaporated to a final volume of 0.1 ml.
In order to determine recoveries of the analytes from extraction cartridges, distilled water was spiked with neutral drugs at concentrations of 500 ng/L. Flow rates through the cartridges were optimized for best recoveries and times to extraction. Average recoveries (n ϭ 3) were comparable to previously reported values [11] at 89% for carbamazepine, 54% for phenazone, 60% for pentoxifylline, 54% for ifosfamide, 60% for cyclophosphamide, and 89% for dihydrocarbamazepine (internal standard). Once again, the recoveries of neutral drugs dissolved in distilled water may not reflect the recoveries of these analytes from effluent matrices.
Derivatization and analysis of acidic drugs
Extracts prepared for analysis of acidic drugs were methylated by a modification of the derivatization procedure described by Lee et al. [13] involving methylation with methanol in the presence of BF 3 reagent. Subsequent to this study, an analytical method for acidic drugs was developed involving LC-MS/MS analysis in negative ion mode [14] . Meclofenamic acid (100 l of 10-g/ml stock in methanol) was added to the extracts as an internal standard. Preliminary studies indicated that this compound was not present in detectable concentrations in Canadian STP effluents. The extracts in methanol were then evaporated to a volume of 200 l, and 2 ml of 14% BF 3 / MeOH (Sigma-Aldrich, Toronto, ON, Canada) were added. The samples were heated at 85ЊC for 2 h in a heating block or in a water bath in sealed screw-top centrifuge tubes. After methylation, the derivatized sample was cooled and evaporated to 500 to 750 l. Following evaporation, 3 ml of 1% potassium carbonate in water (HPLC grade) and 2 ml petroleum ether (distilled in glass) were added to the sample. After vortexing for 1 min, the organic and aqueous layers were allowed to separate, and the organic layer was removed with a pipette and dried by passing through Na 2 SO 4 (prewashed, 5-cm bed). This procedure was repeated twice more, and the Na 2 SO 4 column was rinsed with petroleum ether. The sample was evaporated to a final sample volume of 0.1 ml. However, in some influent samples, it was necessary to dilute sample volumes by 1:10 and to reanalyze because of the exceptionally high concentrations of some analytes (e.g., salicylic acid, naproxen). Derivatized samples were analyzed for the acidic drugs as summarized in Table 2 by GC-MS in selected ion mode using a Hewlett-Packard (Mississauga, ON, Canada) Model 5890 Series II GC equipped with a 30-m DB-5 MS column and a Table 4 . Median and maximum concentrations (g/L) of neutral and acidic drugs in influent and effluent samples (n ϭ 18) collected in 14 Canadian sewage treatment plants in 1998 through 1999. Limits of detection (LODs) in ng/L are also listed. Number ND refers to the number of samples in which the analytes were not detected in the influent or in the effluent. Where indicated by an asterisk (*), analytes were quantified after dilution of the final sample volume by 1:10 . Ion ratios were monitored to ensure that they remained within Ϯ20% of ratios in the standards. Detection limits for acidic drugs in effluent samples were calculated as the second lowest point in the linear portion of the calibration curve [9] . Detection limits for acidic drugs in influent samples were in the range of 100 to 500 ng/L and in final effluent samples were in the range of 50 to 250 ng/L.
Analysis of neutral drugs
Samples were analyzed for the neutral drugs summarized in Table 2 by LC-MS/MS, essentially using the methods and instrumentation described by Ternes et al. [11] . Prior to analysis, dihydrocarbamazepine was added as an internal standard (50 l of a stock of 10 g/ml in methanol). The volume of the sample extracts in methanol were then reduced to about 20 l and diluted with phosphate buffer (20 mmol/L, pH 7) to a final volume of 0.5 ml. Phosphate buffer is preferable for storage of the extracts without degradation of analytes. The HPLC column was a 125 ϫ 3-mm Merck LiChrosphere 100 RP-18 column (5 m) with a flux rate of 0.4 ml/min. The analytes were eluted in a gradient consisting of a binary mixture of two buffers: buffer A, water/acetonitrile containing 5 mmol/L ammonium acetate (pH 5.7) and 10% acetonitrile, and buffer B, 40% buffer A and 60% acetonitrile, and the gradient varied from 100% buffer A at time 0 to 100% buffer B at 18 min. Analytes were analyzed with a Perkin-Elmer/Sciex (Frankfurt, Germany) API III MS system consisting of a triplestage quadrupole mass spectrometer with electrospray ionization operated in positive ion mode. Precursor (MϩH) ϩ ions were isolated, and product ions were monitored as summarized in Table 3 . Detection limits for neutral drugs in STP samples were calculated as the second lowest point in the linear portion of the calibration curve [11] . Detection limits in influent samples were in the range of 500 to 1,000 ng/L and in final effluent samples were in the range of 100 to 250 ng/L (Table 4) .
Quantitation
Changes in the retention times and matrix-induced signal suppression have been observed when acidic drugs extracted from sewage effluent matrices are analyzed by GC-MS [9] . Similarly, matrix-induced signal suppression occurs when neutral drugs extracted from sewage effluents are analyzed by LC-MS/MS [11] , probably through competition between the analyte ions and matrix components for gas-phase emission in the electrospray ionization source [15] . In the absence of certified 13 C internal standards for the neutral and acidic drugs, it was necessary to correct for matrix effects by developing a calibration curve with external standards spiked into a sewage matrix. Therefore, different concentrations of drug analytes were spiked into reference samples of sewage influent and effluents collected from the STP in Peterborough. These spiked samples were extracted and analyzed to develop a calibration curve that reflected matrix-induced reductions in analytical sensitivity. This calibration method may contribute to analytical variability because of variations in the sample matrices between sewage treatment plants (including the reference STP), but few options exist until stable isotope internal standards become commercially available. Samples were quantified against calibration curves prepared by analyzing standards of neutral or acidic drugs spiked into effluent and influent samples collected from the Peterborough STP in September 1998. Aliquots (250 ml) of the influent and effluent samples were spiked with various amounts of stock solutions of drug analytes to yield final concentrations of 0 (blank), 10, 50, 100, 250, 500, 2,000, and 5,000 ng/L. These samples were extracted and derivatized (in the case of acidic drugs) using the methods described previously and analyzed to give a calibration curve over the range of concentrations of drugs detected in the STP samples. Regressions, which varied in correlation coefficients from 0.78 to 0.94, were calculated for the calibration curves. The y-intercepts accounted for background concentrations of drugs in the Peterborough STP. Detection limits were estimated as the second lowest point on the linear portion of the calibration curves.
RESULTS AND DISCUSSION
Several acidic and neutral drugs were detected at g/L concentrations in the influents and effluents of Canadian STPs. Table 4 provides a summary of the median and maximum concentrations of acidic drugs in influent and effluent samples, and the complete data set is presented in Appendix 1. Figure  2 illustrates a chromatogram for an effluent sample from plant A. Ibuprofen is the active ingredient in commonly used nonprescription antiphlogistic drugs (e.g., Advil, Boots, Nottingham, UK), and this drug was identified over a decade ago in effluents from the STP for the city of Vancouver [7] . Related compounds, fenoprofen and ketoprofen, were detected in the influents of a few STPs, but concentrations in the effluent samples were all below detection limits (Table 4) . Naproxen is a commonly prescribed anti-inflammatory drug used in both human and veterinary applications [2, 16] , and this drug was also previously identified in effluents from the STP for the city of Vancouver [7] . Naproxen was detected in both the influent and final effluent of STPs in three cities (plants D, Q, and R) where concentrations in effluent were 7.2, 33.9, and 9.5 g/L, respectively. In most STPs sampled, naproxen was present at g/L concentrations in the influent samples but was not present at detectable levels in the corresponding final effluent (Table 4 ).
The sampling arrangements may have influenced the analytical results. Small volumes of influent and effluent (250 ml) were extracted at each STP, which may have contributed to observations of concentrations below detection limits. Although every effort was made to minimize shipping and storage times, degradation of analytes may have occurred over the period of shipping of the sewage samples from the sampling site and subsequent storage at the laboratory where solid-phase extraction was conducted. Once the samples were extracted onto SPE cartridges and dried, it unlikely that degradation of the analytes occurred over the 2 to 3 d prior to elution from the cartridges in methanol. Degradation would have been minimized by adsorption onto the solid phase, removal of water from the cartridge by drying, and refrigeration during shipping and storage.
The methylation procedure with methanol in the presence of BF 3 reagent was different than the methylation procedure with diazomethane described by Ternes et al. [9] . The derivatization procedure used in this study requires a 2-h reaction time at an elevated temperature. Acetylsalicylic acid (ASA), which is relatively unstable in aqueous matrices, degrades during this methylation procedure to salicylic acid. Therefore, it was not possible to determine levels of ASA and salicylic acid individually in this study. Any ASA present in effluent and influent samples would be reflected in the levels of salicylic acid. This methylation procedure also degraded the acidic analgesic drug indomethacin, so it was not possible to analyze this drug in effluent samples. However, subsequent studies in our laboratory without derivatization of samples and LC-MS/ MS analysis of acidic drugs have shown that indomethacin is present in Canadian STP effluents [14] . Meclofenamic acid was used as an internal standard to assess the efficiency of the methylation procedure. However, it cannot be discounted that methylation efficiencies varied for meclofenamic acid and the other acidic drug analytes.
Salicylic acid was present in all influent samples and in several effluent samples, sometimes at very high concentrations (Table 4 ). The high concentrations of salicylic acid may reflect high usage of ASA as a nonprescription analgesic/antiinflammatory in Canada. The concentrations of salicylic acid in final effluents from Canadian STPs were very similar to the levels of salicylic acid reported in the final effluents of an STP in Kansas City (KS, USA) (2.4-95.6 g/L) sampled in the mid-1970s [8] . However, many other sources of salicylic acid exist in the environment, including industrial discharges [8] . Salicylic acid is a natural plant product, especially in fruits, and therefore may be present in STPs through discharges of food waste or through storm-water runoff in those municipalities that have combined domestic sewers and storm sewers. As mentioned previously, ASA was degraded to salicylic acid during methylation, so some of the salicylic acid detected in samples may have originated from ASA.
The maximum concentrations of the analgesic/anti-inflammatory drugs ibuprofen, naproxen, and salicylic acid in the final effluents of STPs in Canada were greater than the maximum concentrations previously reported for STP effluents in Germany [2, 4] . For instance, the maximum concentration of ibuprofen detected in German STP effluents was 3.4 g/L [2] , while ibuprofen was detected in the final effluents from STPs in three large Canadian cities, plants P, Q, and R, at concentrations of 21.7, 24.6, and 18.5 g/L, respectively. These high concentrations in the STPs of some Canadian cities may reflect differences between Germany and Canada in the usage of pre-Environ. Toxicol. Chem. 22, 2003 C.D. Metcalfe et al. scription and nonprescription analgesic/anti-inflammatory drugs. However, a more likely explanation is poor rates of removal of drugs in Canadian STPs. Among the STPs sampled in this study, secondary treatment technologies were the most prevalent, and one STP used only primary treatment (Table  1) . Tertiary treatment technologies are generally employed in German STPs. In addition, Canadian STPs with combined storm-water and domestic sewage inflows are subject to overcapacity events that may reduce treatment efficiencies [3] . Sewage treatment efficiencies in Canadian STPs may also be reduced by cold weather in the winter months. Since the sampling schedule in this study was distributed over a six-month period from September 1998 to February 1999 (Table 1) , low ambient temperatures may have reduced pharmaceutical removal rates in the STPs sampled during the winter. Also, seasonal changes in the use of pharmaceuticals to treat the symptoms of viral infections (e.g., colds, influenza) may also have affected these data. In contrast to the general pattern of high concentrations of anti-inflammatory drugs in Canadian STPs, the analgesic and anti-inflammatory drug diclofenac was not detected in any of the final effluent samples and was detected in only one influent sample (plant C) at a concentration of 1.3 g/L. However, in a separate study, we detected diclofenac in the final effluent of an STP for the municipality of Whitby (ON, Canada) [14] . In Europe, diclofenac is a highly prescribed analgesic and is commonly found in sewage effluents and in surface waters near STPs [2, 4, 17] .
The acidic lipid regulator gemfibrozil was detected in influent samples from three STPs (plants E, L, and R) and in one effluent sample (plant Q) at a concentration of 1.3 g/L (Table 4) . Bezafibrate was also detected in influent samples from several STPs but was present in the final effluents of only two STPs (plants D and R). Clofibric acid, the active metabolite of clofibrate, was not detected in any samples of effluents or influents. These lipid-regulating compounds are commonly found in Europe in sewage effluents and in surface water [2, 4, 9, [18] [19] [20] and have also been detected in tap water [20, 21] . Clofibric acid was detected at g/L concentrations in the effluents of the Kansas City STP in the mid-1970s [8] . These drugs are presently used in large quantities in Europe to reduce serum cholesterol [2] . The lower prevalence of these compounds in samples from Canadian STPs may be due to preferences for other classes of lipid-regulating drugs in Canada, such as members of the statin class of drugs, including atorvastatin ( [22] ; http://www.imshealthcanada.com). However, clofibric acid is probably present at low concentrations in some Canadian STP effluents, as this compound was detected at a concentration of 19 ng/L in an effluent sample collected in 1997 from the STP of the town of Whitby (C. Metcalfe and T. Ternes, unpublished data). Clofibric acid was not detected in the sewage effluent from Whitby in a subsequent sampling period [14] .
The neutral drug carbamazepine was found in every influent and effluent sample tested, with concentrations in final effluents up to 2.3 g/L (Table 4) . This drug, which was originally developed for the treatment of epilepsy, is now being prescribed for treatment of a range of other medical conditions, such as chronic pain [23] . Carbamazepine is commonly detected in STP effluents in Germany at concentrations up to 6.3 g/L and has also been detected in surface water [2, 4] and drinking water [21] . Carbamazepine was detected but not quantified in some well-water samples from northern Nevada (USA) [24] . In some German groundwater samples, relatively high concentrations of carbamazepine (up to 1.1 g/L) were detected [21, 25] .
Among the other neutral drugs analyzed in this study, relatively few were detected in influent or effluent samples. The cancer chemotherapy drugs ifosfamide and cyclophosphamide and the prescription anti-inflammatory phenazone were not detected in any of the samples. The vasodilator drug pentoxyfylline was detected at ng/L concentrations in the final effluents of three STPs (plants D, O, and P) and in the final basin of a treatment lagoon (plant L). However, this compound was not detected in any of the influent samples from the same STPs (Table 4) .
Comparisons of the concentrations of drugs in STP influent and effluent samples must be interpreted with caution. In STPs, sewage is retained for treatment for several hours, and sewage in lagoons is retained for several weeks before discharge. Therefore, the composition of effluent exiting an STP or lagoon does not necessarily reflect the composition of the influent sampled on the same day. It is also possible that drugs entering STPs in their conjugated form become microbially deconjugated prior to discharge, as has been observed for estrogen hormones [26] . Thus, it is not surprising that in several cases in this study, drugs were detected in effluent samples but were not detected in the influent samples from the same STP (e.g., pentoxyfylline). Concentrations of carbamazepine in influent and effluent samples from the same STP or lagoon were generally approximately equal (Table 4) . These data could be interpreted as evidence of resistance to degradation by carbamazepine during sewage treatment, as has been suggested previously for German STPs [2] . Concentrations of naproxen in influent samples were generally high, but this drug was not present in the effluents of the majority of STPs (Table 4) . These data could be interpreted as evidence of high elimination rates for this drug in STPs.
It was difficult to determine whether trends relating operational parameters to the rates of drug elimination exist because few drugs were detected consistently in both influent and effluent samples. However, salicylic acid, ibuprofen, naproxen, and carbamazepine were present in both the influent and the effluent samples of several STPs. Since salicylic acid is a metabolite of ASA, analysis of the removal rates of this compound are not likely to be helpful in the absence of data on ASA concentrations. Figure 3 illustrates the percentage removal ([C influent Ϫ C effluent ]/C influent ϫ 100) for ibuprofen, naproxen, and carbamazepine in the STPs in relation to the length of time that sewage was retained in the STP (hydraulic retention time [HRT] ). Note that this analysis does not include the data for sewage lagoons and does not include those STPs where the analytes were detected in effluent but not the influent (n ϭ 1 for naproxen, n ϭ 2 for ibuprofen). A first-order equation for percentage removal ϭ 1.735·e (0.886ϫHRT) (r 2 ϭ 0.58) can be used to predict removal from data on hydraulic retention times. These data indicate that ibuprofen and naproxen are eliminated efficiently (Ͼ90%) in STPs where HRTs are greater than approximately 12 h. On the other hand, the percentage removal for carbamazepine in the STPs was always less than 50%, and concentrations were frequently greater in the effluent than the influent (Fig. 3) . These data indicate that this neutral drug is poorly eliminated by sewage treatment, no matter how great the HRT. Figure 4 illustrates the percentage removal for ibuprofen, naproxen, and carbamazepine in the STPs in relation to the length of time that sewage solids were retained in the STP (solids retention time [SRT] ). These data show no trends relating removal rates to retention of biosolids in the treatment system. For the four municipalities with sewage lagoons, the rates of removal of ibuprofen and naproxen appeared to be high (Fig. 5) . However, the percentage removal of carbamazepine in the lagoons appeared to vary from 5 to 25%, with one lagoon (plant K) having a higher concentration of carbamazepine in the effluent than the influent. These data must be interpreted with caution because of the very long residence times of sewage in lagoons (Ͼ150 d).
Sewage treatment is a complex process that varies with time and season within individual STPs and varies between STPs according to the type and quantity of sewage, the sewage retention time, the treatment technology, and the method of disinfection [1, 3] . A more productive method of evaluating the role of treatment parameters on drug elimination may be to evaluate drug concentrations relative to a marker compound, such as caffeine [12] . Overall, these drug residue data illustrate that pharmaceuticals are present in STP effluents in North America, and this contamination is not confined to Europe. Further work is needed to determine the distribution of these drugs in surface water, groundwater, and drinking water in North America.
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APPENDIX.
Concentrations (g/L) of neutral and acidic drugs in the influent and effluent of Canadian sewage treatment plants sampled in 1998 through 1999. The plant identification numbers correspond to 
